All articles tagged with #eye drops
The FDA issued a Class II recall of about 2.5 million bottles of prednisolone acetate ophthalmic suspension 1% eye drops by Lupin Pharmaceuticals due to a potential foreign-substance contamination. The products—available in 5 mL, 10 mL, and 15 mL sizes—were initially recalled on June 4 and reclassified on June 30; the drops treat non-infectious eye allergies and inflammation.
The FDA has recalled more than 2.5 million bottles of Lupin's prednisolone acetate eye drops due to a possible foreign substance; the substance and its entry method aren’t identified. The affected bottles (5 mL, 10 mL, 15 mL) are from India-based Lupin and are used to reduce inflammation after eye surgery or for allergies. Because this is a Class II recall (high risk), patients should not stop using the product on their own and should consult an eye doctor or pharmacist for guidance based on their condition.
Lupin Pharmaceuticals is recalling more than 2.5 million prednisolone acetate eye drops in the U.S. due to a foreign substance; manufactured in India and sold in 5 mL, 10 mL, and 15 mL bottles with expiry dates from July 31, 2026 to March 31, 2028; the FDA class II recall indicates potential temporary health effects, though no injuries have been reported; Lupin did not immediately respond to questions, and the recall began in early June.
The FDA is recalling more than 2.5 million bottles of Prednisolone Acetate Ophthalmic Suspension eye drops from Lupin Pharmaceuticals due to a possible foreign substance; the Class II recall indicates temporary or reversible health effects, and consumers should immediately stop using the recalled bottles and check the FDA enforcement report for affected lots.
A team from the National University of Singapore developed LEAF—light-reaction enriched thylakoid NADPH-foundry—by delivering spinach-derived photosynthetic machinery as eye drops. When exposed to ambient light, the transplanted thylakoids generate NADPH in mammalian eye cells to counter ROS, reducing inflammation associated with dry eye. In lab tests and mice, LEAF outperformed Restasis and tear-fluid assays showed oxidant reductions; clinical trials are planned. However, the particles degrade within hours and long-term efficacy and safety in humans remain to be determined, with potential applications for other light-activated therapies.
Fox News highlights practical spring allergy relief with budget-friendly picks, including HEPA air purifiers, humidifiers, nasal rinses, nasal strips, and antihistamine/eye drops, plus tips to curb indoor allergens with cleaning tools and pet-dander management. The piece emphasizes items like Levoit purifiers, Navage and NeilMed nasal care, Vicks saline spray, eye-relief drops, and skin care to ease itchy eyes, congestion, and dry skin while noting ongoing deals and discounts.
New specially formulated eye drops containing pilocarpine and diclofenac can rapidly improve near vision in presbyopia patients, with effects lasting up to two years and minimal side effects, offering a promising non-invasive alternative to glasses and surgery.
Researchers have developed special eye drops containing pilocarpine and diclofenac that can improve near vision in presbyopia patients, potentially reducing the need for reading glasses. The study showed significant and sustained improvements over two years, though further research is needed to confirm safety and effectiveness. These drops offer a promising non-invasive alternative for those who cannot undergo surgery or prefer to avoid glasses.
A retrospective study suggests that daily use of specially formulated eye drops containing pilocarpine and diclofenac can significantly improve near vision in presbyopia patients for up to two years, potentially reducing dependence on reading glasses, with minimal side effects.
A study presented at the ESCRS suggests that special eye drops containing pilocarpine and diclofenac could effectively improve near vision in people with presbyopia, potentially replacing glasses or surgery, with sustained results over two years and minimal side effects.
Researchers have developed peptide-based eye drops that target Toll-like receptor pathways to reverse vision loss caused by age-related macular degeneration, showing promising results in mouse models and offering a less invasive treatment option.
The FDA has issued a warning against copycat eye drops, including South Moon, Rebright, and FivFivGo, due to the risk of infection and lack of proper ingredients. Testing revealed that South Moon was contaminated with bacteria, while Rebright lacked the active ingredient found in the authentic product. The agency advised consumers to purchase eye drops only from reputable retailers and cautioned against using these copycat products, which claim to address conditions like glaucoma but lack proper approval and ingredients.
Amazon has voluntarily removed seven eye drop brands from their platform in response to a warning letter from the FDA regarding potential safety concerns. The eye drops, marketed as homeopathic treatments for various eye conditions, have not been formally approved by the FDA. This comes after recent recalls of eye drop products due to insanitary conditions and contamination. Consumers are advised to seek medical attention if they experience any adverse reactions and to properly discard the recalled products.
The US Food and Drug Administration (FDA) has warned Amazon for selling seven brands of eye drops that are considered "unapproved new drugs." The FDA stated that these products can be classified as "new drugs" being distributed without FDA approval, which violates federal regulations. Amazon has started removing the products from its online marketplace. This warning follows previous FDA alerts about contaminated eye drops, which can lead to eye infections and vision loss. The FDA has urged caution regarding the use of certain eye drop products due to contamination from bacteria or fungus.
The US Food and Drug Administration (FDA) has warned Amazon for selling seven brands of eye drops that are considered "unapproved new drugs." The FDA stated that these products can be classified as "new drugs" being distributed without FDA approval, which violates federal regulations. Amazon has started removing the products from its online marketplace. This warning follows previous FDA alerts about contaminated eye drops, which can lead to eye infections and vision loss. The FDA has urged caution regarding the use of certain eye drop products due to contamination from bacteria or fungus.